ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 88 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q2 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| X-Square Capital, LLC | 26,771 | $25 | 0.02% |
| Baillie Gifford | 17,176,135 | $15,887,926 | 0.01% |
| Newman Dignan & Sheerar, Inc. | 19,364 | $17,912 | 0.01% |
| CSS LLC/IL | 90,702 | $83,899 | 0.01% |
| HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | 25,500 | $24 | 0.01% |
| Rathbones Group PLC | 432,818 | $400,356 | 0.00% |
| PERSONAL CFO SOLUTIONS, LLC | 19,388 | $17,934 | 0.00% |
| GSA CAPITAL PARTNERS LLP | 34,307 | $32 | 0.00% |
| CORNERCAP INVESTMENT COUNSEL INC | 13,166 | $12,179 | 0.00% |
| Renaissance Technologies | 1,506,375 | $1,393 | 0.00% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 25,181 | $23,292 | 0.00% |
| Bayesian Capital Management, LP | 11,586 | $10,717 | 0.00% |
| HighMark Wealth Management LLC | 1,269 | $1,174 | 0.00% |
| Citadel Advisors | 3,370,083 | $3,117,327 | 0.00% |
| Narwhal Capital Management | 10,344 | $9,568 | 0.00% |
| China Universal Asset Management Co., Ltd. | 1,918 | $2 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 358,010 | $329 | 0.00% |
| OPPENHEIMER & CO INC | 68,171 | $63,058 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 110,174 | $101,911 | 0.00% |
| BNP PARIBAS FINANCIAL MARKETS | 1,714 | $1,585 | 0.00% |
External links
This page lists ADAPTIMMUNE THERAPEUTICS PLC's shareholders in Q2 2023. To view ADAPTIMMUNE THERAPEUTICS PLC's shareholder history, click here.